Verrica Pharmaceuticals Inc VRCA:NASDAQ

RT Quote | Last NASDAQ LS, VOL From CTA | USD
after hours iconAfter Hours: Last | 4:00 PM EDT
9.15UNCH (UNCH)
Volume
3,109
Close
9.15quote price arrow up+0.05 (+0.55%)
Volume
174,188
52 week range
2.86 - 11.41
Loading...
  • Open8.97
  • Day High9.67
  • Day Low8.85
  • Prev Close9.10
  • 52 Week High11.41
  • 52 Week High Date05/14/24
  • 52 Week Low2.86
  • 52 Week Low Date11/14/23

Key Stats

  • Market Cap388.143M
  • Shares Out42.42M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.79
  • YTD % Change25

KEY STATS

  • Open8.97
  • Day High9.67
  • Day Low8.85
  • Prev Close9.10
  • 52 Week High11.41
  • 52 Week High Date05/14/24
  • 52 Week Low2.86
  • 52 Week Low Date11/14/23
  • Market Cap388.143M
  • Shares Out42.42M
  • 10 Day Average Volume0.35M
  • Dividend-
  • Dividend Yield-
  • Beta1.79
  • YTD % Change25

RATIOS/PROFITABILITY

  • EPS (TTM)-1.75
  • P/E (TTM)-5.24
  • Fwd P/E (NTM)-7.00
  • EBITDA (TTM)-74.045M
  • ROE (TTM)-243.35%
  • Revenue (TTM)8.913M
  • Gross Margin (TTM)79.63%
  • Net Margin (TTM)-905.83%
  • Debt To Equity (MRQ)3,003.18%

EVENTS

  • Earnings Date08/06/2024(est)
  • Ex Div Date-
  • Div Amount-
  • Split Date-
  • Split Factor-

Latest On Verrica Pharmaceuticals Inc

 

Profile

MORE
Verrica Pharmaceuticals Inc. is a dermatology therapeutics company. The Company is focused on developing and commercializing treatments for skin diseases. Its product pipeline consists of three product candidates: YCANTH, VP-315 and VP-103. YCANTH is a proprietary drug-device combination that contains a GMP-controlled formulation of cantharidin. We are also developing YCANTH for potential follow-on indications for the treatment of common warts and external genital warts. In...
Paul Manning
Chairman of the Board
Ted White
President, Chief Executive Officer, Director
P. Terence Kohler Jr.
Chief Financial Officer
Christopher Hayes J.D.
General Counsel, Company Secretary, Chief Legal Office
Address
10 N High St Ste 200
West Chester, PA
19380-3014
United States

Top Peers

SYMBOLLASTCHG%CHG
MGTX
MeiraGTx Holdings PLC
5.68+0.15+2.71%
PGEN
Precigen Inc
1.40-0.04-2.78%
NAUT
Nautilus Biotechnology Inc
2.92+0.05+1.74%
BDTX
Black Diamond Therapeutics Inc
5.24-0.20-3.68%
TNYA
Tenaya Therapeutics Inc
4.25UNCHUNCH